EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro

Paula Helena Sieber iD, Dirk Steinritz, Franz Worek, Harald John iD

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3776 ↗

At a glance

Journal article in Drug Testing and Analysis, 2025. Written by Paula Helena Sieber and 3 co-authors. Institution: Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany. Major MEDLINE topics: Serum Albumin, Human, Disulfides, Acetylcysteine. Cited 5 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: German Research Foundation (DFG), Deutsche Forschungsgemeinschaft.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Malodorants comprise notoriously smelling mercaptans and might be applied for crowd control. Because exposure to malodorants may lead to irritation of the respiratory system, choking, and coma, bioanalytical verification of poisoning might be required in a medical and forensic context. We herein present the detection and identification of novel biomarkers of exposure to ethyl mercaptan, n ‐butyl mercaptan, tert ‐butyl mercaptan, and iso ‐amyl mercaptan. These alkyl thiol compounds were found to form disulfide adducts in human serum albumin (HSA) in plasma in vitro with the only non‐disulfide‐bridged Cys 34 residue and with other residues being part of the disulfide‐bridged pattern in HSA. After proteinase K‐catalyzed proteolysis, adducts of all mercaptans were detected simultaneously as the tripeptide Cys 34 *ProPhe and the dipeptides Cys 369 *Tyr, ValCys 316 *, and Cys x *Ala (x denominates either Positions 91, 200, 253, 361, and/or 448) by a sensitive micro‐liquid chromatography–electrospray ionization tandem mass spectrometry (μLC‐ESI MS/MS) method working in the scheduled multiple reaction monitoring (sMRM) mode. Time‐ and concentration‐dependent adduct formations while exposure and proteolysis were investigated and the suitability of adducts as biomarkers of exposure was elaborated. Adducts at Cys 34 showed the lowest limits of identification (LOIs, 6 nM to 1.2 μM mercaptan in plasma) and superior stability in plasma at 37°C. Therefore, Cys 34 *ProPhe appears as the most promising target to prove exposure to mercaptans at least in vitro.

Subjects

MeSH terms (MEDLINE)

Serum Albumin, HumanDisulfidesAcetylcysteineHumansBiomarkersTandem Mass SpectrometrySpectrometry, Mass, Electrospray IonizationChromatography, LiquidSulfhydryl Compounds

Author keywords

disulfide adductshigh‐resolution tandem mass spectrometryprotein adductsscheduled multiple reaction monitoringverification

Substances

BiomarkersSerum Albumin, HumanDisulfidesAcetylcysteineSulfhydryl Compounds

Authors and institutions

  • Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany.
  • Walther-Straub-Institute of Pharmacology and Toxicology, LMU Munich, Munich, Germany.

ORCID profiles: Paula Helena Sieber, Harald John

Funding

  • German Research Foundation (DFG)
  • Deutsche Forschungsgemeinschaft

Cite

APA

Sieber, P. H., Steinritz, D., Worek, F., & John, H. (2025). Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro. Drug Testing and Analysis. https://doi.org/10.1002/dta.3776

Vancouver

Sieber PH, Steinritz D, Worek F, John H. Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro. Drug Testing and Analysis. 2025. doi:10.1002/dta.3776

BibTeX
@article{Sieber2025,
  author = {Sieber, Paula Helena and Steinritz, Dirk and Worek, Franz and John, Harald},
  title = {Mercaptans in malodorants break disulfide bridges in human serum albumin and form adducts suitable as biomarkers of exposure in vitro},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3776}
}
Start for free →